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 Dear Editor,
 Freitas C et al1 recently published a case report on a 
widely discussed topic in psychiatry, concerning the risk of 
manic switch with the use of antidepressants. This topic is of 
the utmost importance especially considering today’s wide-
spread use of antidepressants in a wide range of medical 
conditions. Although the risk of switching with antidepres-
sants is well established, its adverse effects in the manage-
ment in other clinical conditions are often underestimated in 
psychiatry. At the core of this issue is the accurate diagnosis 
of depressive episodes. Today’s classification systems on 
mood disorders are largely based on a polarity dichotomy 
(unipolar versus bipolar). Frequently it is assumed that 
any depressive state is synonymous with the diagnosis of 
unipolar depression, overlooking subsyndromal signs of 
hypomanic or mixed depressive states. A previous history 
of treatment resistant depression, irritability, mood lability, 
mixed features in response to antidepressants is associ-
ated with a possible underlying bipolar diathesis.2 Indeed, 
some authors propose that up to half of supposedly unipo-
lar depressive episodes presenting in clinical practice might 
be diagnosed as depressive mixed states if one takes into 
consideration criteria excluded from DSM 5 mixed features 
specifier (such as psychomotor agitation, distractibility, ir-
ritability, racing thoughts).3,4 Radical thinkers go as far as 
proposing the apparently controversial view that depres-
sion is a consequence of manic states.3 According to this 
point of view, antidepressants are ineffective and harmful 
in the treatment of most depressive episodes presenting in 
clinical practice, and thus contribute to induce further mood 
instability in these patients. Indeed, most depressive states 
in clinical practice would involve mixed depressive states, 
affective temperaments (cyclothymia and hyperthymia) and 
classical bipolar depression.5 Misdiagnosis of soft bipolar 
spectrum disorders or temperamental dysregulations (such 
as cyclothymia) may lead to frustration amongst clinicians 
with patients failing to improve and apparently resisting to 
recommended pharmacological and psychological treat-
ment. The mainstay treatment should include the slow dis-
continuation of antidepressants and the use of drugs with 
mood stabilizing properties (lithium, anticonvulsants and 
second-generation antipsychotics).4,5 Current evidence 
would recommend against the use of antidepressant mono-
therapy in the treatment of bipolar spectrum depression. 
The key message is to be mindful of associated features 
and signs that depressive episodes (even in the absence of 
past mania or hypomania) might not be truly ‘unipolar’ (Ta-
ble 1). This might help to prevent misdiagnosis and inappro-
priate treatment strategies with potential negative long-term 
prognostic implications (including increased suicide risk).
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Table 1 – Features that might indicate non-unipolar depressive episodes
Symptom profile including irritability, distractibility, inner tension, impulsivity, excitement
Atypical depression (mood reactivity, exaggerated interpersonal sensitivity, increased appetite and hypersomnia)
High comorbidity (anxiety, eating and impulse control disorders, adult attention deficit and hyperactivity disorder, personality disorders 
with cluster b features, including borderline and histrionic personality disorders)
Early age of onset
Post-partum depression
Seasonal depression
Treatment resistant depression
Family history of bipolar disorder
Hyperthymic or cyclothymic premorbid affective temperament
